Medplus Health approves ₹130 Cr equity share buyback

Medplus Health Services Ltd announced its Board of Directors has approved a buyback of equity shares worth up to ₹130.00 Crores (approx. 9.87% of paid-up capital and free reserves as of March 31, 2026). The buyback will be conducted through the open market route at a maximum price of ₹750 per share. Promoters and persons in control will not participate. The company has appointed Nuvama Wealth Management Limited as the Manager to the Buyback and a Buyback Committee has been constituted to oversee the process.